The market size of Duchenne Muscular Dystrophy in the 7MM was found to be USD 266.06 Million in 2017. The United States accounts for the largest Duchenne Muscular Dystrophy (DMD) market size in comparison to EU5 and Japan.
The total diagnosed DMD prevalent population in 2017 was 27,685 (in 7MM).
The key players in Duchenne Muscular Dystrophy Market include Sarepta Therapeutics, Santhera Pharmaceuticals, Italfarmaco, Catabasis Pharmaceuticals, NS Pharma, Pfizer, Taiho Pharmaceutical, FibroGen, Daiichi Sankyo, Nobelpharma, and many others.
For more details visit: https://www.delveinsight.com/report-store/duchenne-muscular-dystrophy-market#infographics